Artificial Intelligence in the Cancer Market: Transforming Diagnosis and Treatment

Artificial Intelligence (AI) in cancer treatment is set to grow significantly, with the market expected to surge from USD 297.3 billion in 2020 to USD 5,292.8 billion by 2030, at an impressive CAGR of 34.4%. AI, already integral to various aspects of daily life, is increasingly revolutionizing healthcare, particularly in oncology. With the vast number of cancer diagnoses and the extensive data generated during treatment, AI is proving invaluable in enhancing the diagnosis, management, and development of effective therapies. By aiding in information retrieval, image interpretation, and therapy planning during medical procedures, AI not only advances oncologic care but also eases the workload for healthcare professionals.